Cytokinetics
Clinical trials sponsored by Cytokinetics, explained in plain language.
-
New drug trial offers hope for kids with rare heart disease
Disease control Recruiting nowThis study tests a drug called aficamten in children aged 12 to under 18 with a heart condition that makes it hard for blood to leave the heart. The goal is to see if the drug improves heart function and symptoms. About 55 participants will receive either aficamten or a placebo, …
Phase: PHASE2, PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated May 26, 2026 06:20 UTC
-
New drug aims to cut heart failure hospitalizations and deaths
Disease control Recruiting nowThis study tests an investigational drug called omecamtiv mecarbil in 1800 adults with severe heart failure and a very weak heart pump. The goal is to see if the drug can lower the chance of heart failure worsening, needing a heart pump or transplant, or dying. Participants will …
Phase: PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated May 26, 2026 06:15 UTC
-
New hope for stiff heart muscle? drug trial targets HFpEF symptoms
Symptom relief Recruiting nowThis study tests an experimental drug called CK-4021586 in 60 adults with a type of heart failure where the heart pumps normally but is too stiff (HFpEF). Participants will receive either the drug or a placebo for 12 weeks. The main goals are to check safety and see if the drug i…
Phase: PHASE2 • Sponsor: Cytokinetics • Aim: Symptom relief
Last updated May 18, 2026 12:03 UTC